Leerink and Oppenheimer acted as joint book running managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMRX:
- Promising Clinical Trial Results and Favorable Safety Profile Support Buy Rating for Immuneering
- Immuneering Announces $25M Securities Purchase Agreement
- Immuneering announces data from trial of atebimetinib combination
- Immuneering announces Class A common stock offering, private placement
- Immuneering appoints Schall as Chairman of the Board